22 results match your criteria: "Centre INSERM U1219-Epidemiologie-Biostatistique[Affiliation]"
Int J Infect Dis
February 2021
INSERM, Centre INSERM U1219-Epidémiologie-Biostatistique, University of Bordeaux, F-3300 Bordeaux, France; University of Bordeaux, School of Public Health (ISPED), F-33000 Bordeaux, France; CHU de Bordeaux, Hôpital Saint-André, service de Médecine interne et Maladies Infectieuses, F-33000 Bordeaux, France.
Objectives: To cross-sectionally describe brain alterations in PLHIV aged above 50 years old, receiving antiretroviral treatment (ART) and living in Senegal compared to HIV-negative subjects.
Methods: Twenty PLHIV and 26 HIV-negative subjects with comparable socio-demographic and clinical characteristics underwent an MRI exam (3D-T1 and FLAIR sequences). Global atrophy and White Matter Hyperintensities (WMH) were evaluated.
Rev Epidemiol Sante Publique
April 2020
Université de Bordeaux, UFR d'odontologie, Bordeaux, France; Centre hospitalier universitaire de Bordeaux, pôle de médecine et chirurgie bucco-dentaire, Bordeaux, France; Inserm U1219, centre Inserm épidémiologie et biostatistique, université de Bordeaux, Bordeaux, France.
Background: Older persons comprise a growing proportion of the European population and may have a distinct epidemiological oral profile requiring specific preventive and curative care poorly documented. The objectives of this study were to assess the oral health status of people ≥90 years of age in France, to compare their perceived and observed oral care needs and to investigate the oral problems associated with a low oral health-related quality-of-life (OHRQoL).
Methods: An oral cross-sectional study was performed during the 25th follow-up of a cohort of older persons being followed up prospectively for screening of dementia over a 15-year period in Gironde and Dordogne, France.
Inj Epidemiol
July 2019
1Univ. Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, F-33000 Bordeaux, France.
Background: In France, benzodiazepine anxiolytics and z-hypnotics (zolpidem and zopiclone) account for the largest share of road traffic crash risk attributable to exposure to prescription drugs. The aim of this study was to monitor the evolution of the use of these prescription drugs and their association with crash risk over a period that began before the implementation of a color-graded pictogram system printed on prescription drug boxes.
Methods: Data from three French national databases were extracted and linked: the national health care insurance database, police reports, and the national police database of injurious crashes.
J Hepatol
August 2019
Department of Infectious Diseases, Bern University Hospital, University of Bern, Switzerland.
Background & Aims: Robust data on hepatocellular carcinoma (HCC) incidence among HIV/hepatitis B virus (HBV)-coinfected individuals on antiretroviral therapy (ART) are needed to inform HCC screening strategies. We aimed to evaluate the incidence and risk factors of HCC among HIV/HBV-coinfected individuals on tenofovir disoproxil fumarate (TDF)-containing ART in a large multi-cohort study.
Methods: We included all HIV-infected adults with a positive hepatitis B surface antigen test followed in 4 prospective European cohorts.
J Int AIDS Soc
January 2019
Institute for Implementation Science in Population Health, City University of New York, New York, NY, USA.
Introduction: "Treat All" - the treatment of all people with HIV, irrespective of disease stage or CD4 cell count - represents a paradigm shift in HIV care that has the potential to end AIDS as a public health threat. With accelerating implementation of Treat All in sub-Saharan Africa (SSA), there is a need for a focused agenda and research to identify and inform strategies for promoting timely uptake of HIV treatment, retention in care, and sustained viral suppression and addressing bottlenecks impeding implementation.
Methods: The Delphi approach was used to develop consensus around research priorities for Treat All implementation in SSA.
HIV AIDS (Auckl)
November 2018
INSERM, Centre INSERM U1219-Epidémiologie-Biostatistique, Bordeaux, France,
Background: Reporting mortality and lost to follow-up (LTFU) by age is essential as older HIV-positive patients might be at risk of long-term effects of living with HIV and/or taking antiretroviral therapy (ART). As age effects might not be linear and might impact HIV outcomes in the oldest more severely, people living with HIV (PLHIV) aged 50-59 years and PLHIV aged >60 years were considered separately.
Setting: Seventeen adult HIV/AIDS clinics spread over nine countries in West Africa.
Introduction: Disclosure of HIV status to HIV-infected children and adolescents is a major care challenge. We describe current site characteristics related to disclosure of HIV status in resource-limited paediatric HIV care settings within the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium.
Methods: An online site assessment survey was conducted across the paediatric HIV care sites within six global regions of IeDEA.
Acta Paediatr
March 2018
Pole de Pediatrie, CHU de Bordeaux, Bordeaux, France.
Depression, one of the most common psychiatric disorders, is two- to three-times more prevalent in people living with HIV (PLHIV) than in the general population in many settings as shown in western countries but remains neglected in sub-Saharan Africa (SSA). We aimed to summarize the available evidence on the prevalence of depression and associated factors according to the scales used and the treatment status in PLHIV in SSA. The pooled prevalence estimates of depression ranged between 9% and 32% in PLHIV on antiretroviral treatment (ART) and in untreated or mixed (treated/untreated) ones, with a substantial variability according to the measurement scale used and also for a given scale.
View Article and Find Full Text PDFPLoS One
September 2017
INSERM, ISPED, Centre INSERM U1219-Epidemiologie-Biostatistique, Equipe Prévention et prise en charge des traumatismes, Bordeaux, France.
The role of distractions on attentional lapses that place road users in higher risk of crash remains poorly understood. We aimed to assess the respective impact of (i) mind wandering trait (propensity to mind wander in the everyday life as measured with a set of 4 questions on the proportion of time spent mind wandering in 4 different situations) and (ii) mind wandering state (disturbing thoughts just before the crash) on road crash risk using a comparison between responsible and non-responsible drivers. 954 drivers injured in a road crash were interviewed at the adult emergency department of the Bordeaux university hospital in France (2013-2015).
View Article and Find Full Text PDFJ Acquir Immune Defic Syndr
November 2017
1Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA; 2Sorbonne Universités, INSERM, UPMC Univ Paris 06, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France; 3Institute of Global Health, University College London, London, United Kingdom; 4Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, Madrid, Spain; 5CIBERESP, Instituto de Salud Carlos III, Madrid, Spain; 6AP-HP, Hôpital Antoine Béclère, Service de Médecine Interne, Clamart, France; 7Stichting HIV Monitoring, Amsterdam, the Netherlands; 8Academic Medical Centre, Department of Global Health and Division of Infectious Diseases, University of Amsterdam, Amsterdam, the Netherlands; 9Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands; 10Hospital San Pedro-CIBIR, Logroño, Spain; 11Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, University of Basel, Basel, Switzerland; 12Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; 13Infectious Disease Department, Hospital Parc Tauli, Sabadell, Spain; 14Hospital Clinic-IDIBAPS, Barcelona, Spain; 15Division of Infectious Diseases, Patras University Hospital, Patras, Greece; 16Department of Hygiene, Epidemiology and Medical Statistics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece; 17Université de Bordeaux, ISPED, Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France; 18Centre INSERM U1219- Centre Inserm Epidémiologie et Biostatistique, Université de Bordeaux, Bordeaux, France; 19Department of Internal Medicine, Bordeaux University Hospital, Bordeaux, France; 20Université Paris Sud, UMR 1018, le Kremlin Bicêtre, Paris, France; 21Inserm, UMR 1018, le Kremlin Bicêtre, Paris, France; 22AP-HP, Hôpital de Bicêtre, Service de Santé Publique, le Kremlin Bicêtre, Paris, France; 23Southern Alberta Clinic, Calgary, AB, Canada; 24Department of Medicine, University of Calgary, Calgary, AB, Canada; 25Instituto Nacional de Infectologia Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brasil; 26Programa de Computação Científica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brasil; 27Hospital Universitari Germans Trias i Pujol, Badalona, Spain; 28Department of Internal Medicine, Yale University School of Medicine, New Haven; 29VA Connecticut Healthcare System, West Haven, CT; 30Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston; and 31Harvard-MIT Division of Health Sciences and Technology, Boston, MA.
Background: Clinical guidelines recommend immediate initiation of combined antiretroviral therapy for all HIV-positive individuals. However, those guidelines are based on trials of relatively young participants.
Methods: We included HIV-positive antiretroviral therapy-naive, AIDS-free individuals aged 50-70 years after 2004 in the HIV-CAUSAL Collaboration.
J Biopharm Stat
July 2018
a Univ. Bordeaux ISPED , Centre INSERM U1219-Epidémiologie-Biostatistique, Bordeaux , France.
Clinical trial duration may be a concern in clinical research, especially in cancer trials where the endpoint is overall survival. A surrogate endpoint can be used as an auxiliary variable to analyze the treatment effect earlier. At an early time point, the high number of censored observations can be compensated by the imputation of the unobserved deaths times.
View Article and Find Full Text PDFJ Public Health Dent
June 2017
Université de Bordeaux, UFR, d'Odontologie, Bordeaux, France.
Introduction: The objectives of this study were to investigate the association between HIV infection and dental caries among children in West Africa, and to identify factors associated with dental caries among HIV-infected children.
Methods: We conducted a multi-center cross-sectional study in Mali, Senegal and Côte d'Ivoire with a random sample of HIV-infected children aged 5-15 years on antiretroviral therapy and their uninfected siblings. A standardized examination was performed by calibrated dentists.
PLoS One
August 2017
Bordeaux University, School of Public Health (ISPED), Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France.
Background: In sub-Saharan Africa, antiretroviral therapy (ART) including drugs with potential toxicity such as Zidovudine (ZDV) are routinely prescribed. This study aimed at estimating the incidence of severe neutropenia and associated factors after ART initiation in five West African countries.
Methods: A retrospective cohort analysis was conducted within the international epidemiologic database to evaluate AIDS (IeDEA) collaboration in West Africa.
J Alzheimers Dis
February 2018
INSERM, ISPED, Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France.
Background: There is a growing interest in developing non-pharmacological approaches in dementia. Clinical efficacy of occupational therapy (OT) under routine care conditions has not been investigated yet.
Objective: To analyze the short-term effects of OT in patients with dementia; and to identify factors related to greater benefit.
AIDS
November 2016
aUniversité. Bordeaux, ISPED, Centre INSERM U1219-Epidémiologie-Biostatistique, Bordeaux bINSERM, ISPED, Centre INSERM U1219-Epidemiologie-Biostatistique, Bordeaux, France cProgramme PACCI, site de recherche ANRS, Abidjan, Côte d'Ivoire dBandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau eDepartment of Infectious Diseases fDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark gService des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Côte d'Ivoire hDepartments of Medicine & Global Health, University of Washington, Seattle, Washington, USA iDépartement des Sciences Fondamentales et Santé Publique, Université de Lomé, Lomé, Togo. *See supplemental information for the list of the IeDEA West Africa collaboration members, http://links.lww.com/QAD/A970.
Objectives: HIV-2-infected individuals usually initiate antiretroviral therapy (ART) at an advanced age compared with HIV-1 patients, with a potential impact on treatment outcomes. This study aimed to investigate the effect of sex and age on mortality and loss to follow-up (LTFU) among HIV-2-infected individuals initiating ART.
Methods: Analyses were conducted using the database of the International Epidemiological Databases to Evaluate AIDS's collaboration in West Africa.
AIDS
January 2017
aDepartment of Global Health, Boston University, Boston, Massachusetts, USA bHealth Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa cDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA dCentre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa eDepartment of Infectious Diseases, Bern University Hospital, University of Bern fInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland gThe Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town hDivision of Infectious Diseases, Department of Medicine, University of Stellenbosch & Tygerberg Academic Hospital, Cape Town iAfrica Center for Health and Population Studies, University of Kwazulu-Natal jKheth'Impilo AIDS Free Living, Cape Town kDepartment of Health, Provincial Government of the Western Cape, Cape Town, South Africa lCenter for Infectious Disease Research in Zambia, Lusaka, Zambia mIndiana University School of Medicine, Indianapolis nRichard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA oINSERM U1027, Université Paul Sabatier Toulouse 3, Toulouse pUniversité Bordeaux, ISPED, Centre INSERM U1219 Epidémiologie-Biostatistique, Bordeaux, France.
Objective: We assessed the relationship between phasing out stavudine in first-line antiretroviral therapy (ART) in accordance with WHO 2010 policy and single-drug substitutions (SDS) (substituting the nucleoside reverse transcriptase inhibitor in first-line ART) in sub-Saharan Africa.
Design: Prospective cohort analysis (International epidemiological Databases to Evaluate AIDS-Multiregional) including ART-naive, HIV-infected patients aged at least 16 years, initiating ART between January 2005 and December 2012. Before April 2010 (July 2007 in Zambia) national guidelines called for patients to initiate stavudine-based or zidovudine-based regimen, whereas thereafter tenofovir or zidovudine replaced stavudine in first-line ART.
Br J Clin Pharmacol
December 2016
Centre INSERM U1219-Epidemiologie-Biostatistique, Université de Bordeaux, ISPED, F-33000, Bordeaux, France.
Aims: To assess potential change in medicine exposure and association with the risk of road traffic crash across a time period that started before the implementation of a grading system warning of the effect of medicine on driving performance.
Methods: Data from three French national databases were extracted and matched: the national health care insurance database, police reports and the national police database of injurious crashes. Drivers involved in such crashes in France, from July 2005 to December 2011 and identified by their national identifier, were included.
Nat Genet
September 2016
Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands.
Infect Genet Evol
December 2016
Laboratoire de Biologie Moléculaire et Immunologie (BIOLIM/FSS/UL), Faculté des Sciences de la Santé, Université de Lomé, Togo. Electronic address:
Understanding the HIV epidemic in key populations is important. Today only scarce information is available on HIV-1 strains that circulate in men having sex with men (MSM) in sub-Saharan Africa. Here, we studied for the first time the genetic diversity of HIV-1 strains circulating in the MSM population in Lomé, the capital city from Togo.
View Article and Find Full Text PDFDiabetes Care
May 2016
School of Public Health, University of Pittsburgh, Pittsburgh, PA.
Objective: Previous studies demonstrate that the metabolic syndrome is associated with distal symmetric polyneuropathy (DSP). We aimed to determine the magnitude of this effect and the precise components involved.
Research Design And Methods: We determined the symptomatic DSP prevalence in the Health, Aging, and Body Composition (Health ABC) study (prospective cohort study, with subjects aged 70-79 years at baseline), stratified by glycemic status (glucose tolerance test) and the number of additional metabolic syndrome components (updated National Cholesterol Education Program/Adult Treatment Panel III definition).
J Int AIDS Soc
September 2016
University Bordeaux, ISPED, Centre INSERM U1219-Epidemiologie-Biostatistique, F-33000 Bordeaux, France.
Introduction: Response to antiretroviral therapy (ART) among individuals infected with HIV-2 is poorly described. We compared the immunological response among patients treated with three nucleoside reverse-transcriptase inhibitors (NRTIs) to boosted protease inhibitor (PI) and unboosted PI-based regimens in West Africa.
Methods: This prospective cohort study enrolled treatment-naïve HIV-2-infected patients within the International Epidemiological Databases to Evaluate AIDS collaboration in West Africa.